Erdheim-Chester disease: An orphan condition seeking treatment

Israel Medical Association Journal

Volumn 14, Issue 6, 2012, Pages 388-389

  Mazor, Roei D ^a,c   Kesler, Anat ^b   Shoenfeld, Yehuda ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Erdheim chester disease (ECD); Hairy kidney; Histiocytosis; Interferon (IFN); Interleukin 1 (IL 1)

Indexed keywords

ALPHA INTERFERON; CD68 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; EDITORIAL; ERDHEIM CHESTER DISEASE; HISTIOCYTE; HUMAN; IMMUNE RESPONSE; TH1 CELL;

ERDHEIM-CHESTER DISEASE; HUMANS; MALE;

EID: 84863316812     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Haroche J, Arnaud L, Amoura Z. Erdheim-Chester disease. Curr Opin Rheumatol 2012; 24 (1): 53-9.
2. Al-Quran S, Reith J, Bradley J, Rimsza L. Erdheim-Chester disease: case report, PCRbased analysis of clonality, and review of literature. Mod Pathol 2002; 15 (6): 666-72.
3. Tsai JW, Tsou JH, Hung LY, Wu HB, Chang KC. Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: a rare case with human androgen-receptor gene analysis. J Am Acad Dermatol 2010; 63 (2): 284-91.
4. Chetritt J, Paradis V, Dargere D, et al. Chester-Erdheim disease: a neoplastic disorder. Hum Pathol 1999; 30 (9): 1093-6.
5. Vencio EF, Jenkins RB, Schiller JL, et al. Clonal cytogenetic abnormalities in Erdheim-Chester disease. Am J Surg Pathol 2007; 31 (2): 319-21.
6. Arnaud L, Gorochov G, Charlotte F, et al. Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients. Blood 2011; 117 (10): 2783-90.
7. Dagna L, Girlanda S, Langheim S, et al. Erdheim-Chester disease: report on a case and new insights on its immunopathogenesis. Rheumatology (Oxford) 2010; 49 (6): 1203-6.
8. Stoppacciaro A, Ferrarini M, Salmaggi C, et al. Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis. Arthritis Rheum 2006; 54 (12): 4018-22.
9. Tran TA, Pariente D, Lecron JC, Delwail A, Taoufik Y, Meinzer U. Treatment of pediatric Erdheim-Chester disease with interleukin-1-targeting drugs. Arthritis Rheum 2011; 63 (12): 4031-2.
10. Aouba A, Georgin-Lavialle S, Pagnous C, et al. Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood 2010; 116 (20): 4070-6.
11. Wilejto M, Abla O. Langerhans cell histiocytosis and Erdheim-Chester disease. Curr Opin Rheumatol 2012; 24 (1): 90-6.
12. Arnaud L, Hervier B, Neel A, et al. CNS involvement and treatment with interferonalpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood 2011; 117 (10): 2778-82.
13. Asher I, Ranibovith I, Katz M, Sthoeger Z. Erdheim-Chester disease in a 49 year old man. IMAJ Isr Med Assoc J 2012; 14: 401.